Urogen Pharma Ltd (URGN)

R&D to Revenue

61.12%

Fiscal year · Period ending:

URGN logo

URGN R&D to Revenue

Latest reported61.12%
URGN FY R&D/Revenue (0.00% → 61.12%)
High-resolution chart · PNG

URGN r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
61.1242%
63.2149%
55.1473%
82.2071%
99.1674%
400.9662%
273,872.2222%
3,274.2908%
229.1861%
58.6823%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.